Ian Kirby

Director of Protein Chemistry @ADC Therapeutics

I have a new exciting role at ADC Therapeutics were I hope to bring my expertise in protein chemistry, bio-analytical analysis and label technologies to bear. ADC Therapeutics iare focused on the development of proprietary Antibody Drug Conjugates (ADCs) for the treatment of both solid and hematological cancers. ADC Therapeutics employs monoclonal antibodies specific to particular tumor antigens conjugated to a novel class of highly potent pyrrolobenzodiazepine (PBD)-based warheads to selectively kill cancer cells. ADC Therapeutics already have four assets in Phase I clinical trials